SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that the FDA has approved a content uniformity (CU) method using the Agilent TRS100 Raman quantitative ...
(RTTNews) - Agilent Technologies Inc. (A) said the FDA has approved a content uniformity method using the Agilent TRS100 Raman quantitative pharmaceutical analysis system. The submitting company, Teva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results